Atosiban for threatened preterm birth: the APOSTEL 8 trial – Authors' reply

Research output: Contribution to journal › Comment/Letter to the editor › Academic

32 Downloads (Pure)

Access to Document

@article{3e29e3a742e147e9881d269d16ec29ad,

title = "Atosiban for threatened preterm birth: the APOSTEL 8 trial {\textendash} Authors' reply",

author = "\{van der Windt\}, \{Larissa I.\} and Oudijk, \{Martijn A.\}",

year = "2025",

month = sep,

day = "27",

doi = "10.1016/S0140-6736(25)01569-7",

language = "English",

volume = "406",

pages = "1339--1340",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10510",

}

TY - JOUR

T1 - Atosiban for threatened preterm birth

T2 - the APOSTEL 8 trial – Authors' reply

AU - van der Windt, Larissa I.

AU - Oudijk, Martijn A.

PY - 2025/9/27

Y1 - 2025/9/27

UR - https://www.scopus.com/pages/publications/105016801459

U2 - 10.1016/S0140-6736(25)01569-7

DO - 10.1016/S0140-6736(25)01569-7

M3 - Comment/Letter to the editor

C2 - 41015520

SN - 0140-6736

VL - 406

SP - 1339

EP - 1340

JO - The Lancet

JF - The Lancet

IS - 10510

ER -